Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Pfizer

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jan 18, 2023 12:25pm

135 Views

Post# 35230859

RE:RE:Pfizer

While I am certain that Paul has made a lot of friends at Pfizer during the 35 yr period he worked there we dont know how amicable his departure was and one must know that when a member of higher management leaves a large corporation he becomes persona non grata!Dont expect any favor from PFE

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec